Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s15, 2021. DOI: 10.25251/skin.5.supp.15. Disponível em: https://skin.dermsquared.com/skin/article/view/1168. Acesso em: 19 apr. 2025.